期刊文献+

内脂素基因过表达对大鼠胰岛素敏感性和血浆FGF-21水平的影响 被引量:4

Effects of visfatin gene overexpression on insulin sensitivity and plasma FGF-21 level in rats
原文传递
导出
摘要 目的探讨内脂素基因过表达对大鼠胰岛素敏感性和血浆成纤维细胞生长因子21(FGF-21)的影响。方法构建大鼠内脂素基因重组真核表达质粒,将该质粒转染大鼠。在转染前后采用正糖-高胰岛素钳夹技术评价大鼠胰岛素敏感性变化,并采用放射免疫法测定其血浆FGF-21浓度。结果在质粒注射后3d大鼠血清内脂素水平明显升高(1.49±0.06 vs 0.99±0.04,P〈0.01);葡萄糖输注率(GIR)[(35.3±1.4 vs 27.6±1.7)mg·kg^-1·min^-1,P〈0.01]较注射前明显升高;基础血浆胰岛素水平明显下降[(14.5±3.7 vs24.4±6.2)mU/L,P〈0.05];总胆固醇、高密度脂蛋白胆固醇明显降低[(1.31±0.10 vs 1.76±0.22)mmol/L和(0.59±0.04 vs 0.95±0.15)mmol/L,均P〈0.05];血浆FGF-21也降低[(2.25±0.19 vs 2.59±0.23)μg/L,P〈0.05];在转染前后基础血糖和血浆脂联素水平无明显变化。结论内脂素质粒转染使大鼠血浆visfatin水平升高和FGF-21水平降低,胰岛素敏感性增强。 Objective To investigate the effects of visfatin gene overexpression on insulin sensitivity and plasma fibroblast growth factor 21 (FGF-21) level in rats. Methods The recombinant visfatin plasmid was constructed and transfected into normal rats. The euglycemic-hyperinsulinemic clamp experiments were performed to evaluate the change of insulin sensitivity before and after administration of the plasmid, and plasma FGF-21 level was determined by radioimmunoassay. Results Plasma visfatin levels and glucose infusion rates (GIR) were significantly increased [ ( 1.49 ± 0.06 vs 0. 99 ± 0.04) and ( 35.3 ± 1.4 vs 27.6 ± 1.7 ) mg·kg^- 1·min^-1, respectively, all P 〈 0.01 ]. Fasting insulin level was significantly decreased [ ( 14.5 ± 3.7 vs 24.4 ± 6.2 ) mU/L, P 〈 0.05 ] , total cholesterol and high-density lipoprotein cholesterol were significantly decreased [ ( 1.31 ± 0.10 vs 1.76 ± 0.22 ) mmol/L and ( 0.59 ± 0.04 vs 0. 95 ± 0.15 ) mmol/L, respectively, all P 〈 0.05 ], and plasma FGF- 21 level was also decreased [ (2.25 ± 0.19 vs 2.59 ± 0.23 )μg/L, P 〈 0.05 ] after plasmid being injected 3 days compared with that before injection, but there were no significant differences in fasting glucose and adiponectin levels before and after administration. Conclusion The transfection of visfatin plasmid increases plasma visfatin level, decreases FGF-21 levels and improves insulin sensitivity in normal rats.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2008年第5期542-545,共4页 Chinese Journal of Endocrinology and Metabolism
基金 国家自然科学基金项目(30771037,30871199) 国家教委春晖计划资助项目(2003-56) 美国NIH基金项目(R01HL073267.DK066003)
关键词 内脂素 胰岛素钳夹 胰岛素敏感性 成纤维细胞生长因子21 Visfatin Euglycemic-hyperinsulinemia clamp Insulin sensitivity Fibroblast growth factor-21
  • 相关文献

参考文献9

  • 1Trayhum P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as all endocrine and secretory organ. Proc Nutr Soc, 2001,60:329-339.
  • 2Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science, 2005, 307:426-430.
  • 3Kralisch S, Klein J, Lossner U, et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-LI adipocytes. J Endocrinol, 2005,185: R1 -R8.
  • 4Segawa K, Fukuhara A, Hosogai N, et al. Visfatin in adipocytes is upregulated by hypoxia through HIF1α-dependent mechanism. Biochem Biophys Res Commun, 2006,349:875-852.
  • 5Li L, Yang G, Li Q, et al. Changes and relations of circulating visfatin, apelin and resistin levels in normal, impaired glucose tolerance and type 2 diabetics subjects. Exp Clin Endocr Diab, 2006,114:544-548.
  • 6Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest, 2005,115:1627-1635.
  • 7Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med, 2002,8: 731-737.
  • 8Yamamoto Y, Hirose H, Saito I, et al. Adiponectin an adipocytederived protein predicts future insulin resistance: two-year follow-up study in Japanese population. J Clin Endocrinol Metab, 2004,89: 87- 90.
  • 9Yang G, Li L, Tang Y, et al. Short-term pioglitazone treatment prevents free fatty acid induced hepatic insulin resistance in normal rats: possible role of the resistin and adiponectin. Biochem Biophys Res Commun, 2006,339 : 1190-1196.

同被引文献36

  • 1许樟荣.于世界糖尿病日重谈糖尿病足的诊治与预防[J].中华内分泌代谢杂志,2005,21(6):491-493. 被引量:114
  • 2杨刚毅,张凌,李伶,唐毅,李清明,方超,孙勤,李钶,舒朝忠,Gunther Boden.吡格列酮对脂质诱导胰岛素抵抗大鼠的影响及其机制研究[J].中华内分泌代谢杂志,2006,22(3):273-276. 被引量:9
  • 3刘蓉,朱剑,王茜,沈备,刘翠萍,徐宽枫,茅晓东,刘超.不同糖耐量人群及糖尿病患者血浆内脂素与血糖及胰岛功能的关系研究[J].中国实用内科杂志,2007,27(16):1278-1281. 被引量:89
  • 4Dahl TB, Yndestad A, Skjelland M, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclemsis : possible role in inflammation and plaque destabilization. Circulation,2007,115:972-980.
  • 5Stolk RP, Meijer R, Mail WP, et al. Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference. Am J Clin Nutr,2003,77:857- 860.
  • 6Hammarstedt A, Pihlajamaki J, Rotter Sopasakis V, et al. Visfatin is an adipokine but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab ,2006,91 : 1181-1184.
  • 7European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens ,2003,21 : 1011-1053.
  • 8Filippatos TD, Derdemezis CS, Kiortsis DN, et al. Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome. J Endocrinol Invest, 2007,30 : 323-326.
  • 9Takebayashi K, Suetsugu M, Wakabayashi S, et al. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism ,2007,56:451-458.
  • 10van der Veer E,Nong Z, O'Neil C, et al. Pre-B-cell colony-enhancing factor regulates NAD^+ dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circ Res,2005,97 : 25 -34.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部